大洋洲 · 新闻 · NT News

Health Check: Paradigm calls in the corporate doctors after trial flop

来源：NT News · 澳大利亚 8 小时前

Following the company’s phase III knee osteoarthritis trial failure, Paradigm Biopharmaceuticals' (ASX:PAR) board has called in voluntary administrators to try to salvage value…

在 NT News 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.ntnews.com.au)

Health Check: Paradigm calls in the corporate doctors after trial flop

推荐阅读

Ivan close to tears as Nathan wins Dally M

Ivan close to tears as Nathan wins Dally M

Ivan close to tears as Nathan wins Dally M

Second-hand EVs are better at retaining value than leasing industry claims, according to new study

Jai Arrow told 'nothing' about pre-grand final tribute

Japan turns to AI robots to battle labour shortage

Health Check: Paradigm calls in the corporate doctors after trial flop

分享

推荐阅读

Ivan close to tears as Nathan wins Dally M

Ivan close to tears as Nathan wins Dally M

Ivan close to tears as Nathan wins Dally M

Second-hand EVs are better at retaining value than leasing industry claims, according to new study

Jai Arrow told 'nothing' about pre-grand final tribute

Japan turns to AI robots to battle labour shortage